As DTx products continue to gain momentum and prove to be an integral part of personalized healthcare and value-based care, it is imperative that companies are able to successfully bring these products to market to improve patients’ lives.
Nevertheless, bringing DTx to the mainstream is no small task. There are myriad challenges that can easily inhibit your product’s success, particularly when it comes to aligning stakeholders, achieving payer coverage, and ensuring HCP visibility. Having worked with over 120 small and emerging biotech manufacturers to help bring their innovative therapies to market, we’re here to help.